Palo Alto Networks' stock falls after earnings as forecast fails to impress 
 

The stock was down about 10% in after-hours action Monday. It lost 28% in the session after the last earnings report.


 
Peloton Interactive Gets $1.4 Billion In Fresh Credit 
 

The company will enter a $1 billion five-year term loan facility and a $100 million five-year revolving credit facility.


 
Zoom bumps its longer-term outlook higher, but near-term forecast comes up short 
 

Zoom Video Communications Inc. on Monday bumped its full-year profit and sales forecast higher, after reporting first-quarter results that beat Wall Street's expectations, helped by a broader artificial-intelligence rollout across the video-calling platform's products.


 
Jamie Dimon Says His Retirement Is Getting Closer. Finally. 
 

The JPMorgan chief executive says his timeline "isn't five years anymore."


 
Tesla Shareholder Group Calls for Vote Against Musk Pay Package 
 

The letter calls for shareholders to reject the re-election of two directors, Kimbal Musk and James Murdoch.


 
Johnson Controls Stock Pops on Report Activist Investor Has Built Up Its Stake 
 

A report says Elliott Investment Management has been building a position in the air conditioning and building security supplier.


 
Hims & Hers Health to Offer Injectable Weight-Loss Drugs on Telehealth Platform 
 

Hims & Hers Health shares soared after the company said it would add injectable weight-loss drugs to its platform, granting access to the popular treatments to its telehealth patients.


 
Red Lobster Files for Bankruptcy With Plan to Sell Business and Reduce Locations 
 

The largest seafood restaurant chain in the U.S. failed to recover from dwindling traffic it suffered during the pandemic as menu prices crept higher. An unlimited shrimp deal also took a bite out of earnings.


 
Micron's stock rises as Morgan Stanley admits its bearish stance 'was a mistake' 
 

An analyst said he failed to properly appreciate how high-bandwidth memory would drive stock momentum.


 
Elon Musk's Neuralink Gets FDA Green Light for Second Patient 
 

The brain-chip startup has proposed solutions for a thread pullout problem experienced by its first participant, Noland Arbaugh.


(END) Dow Jones Newswires

05-20-24 1915ET